Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma, Squamous Cell × Acitretin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Carcinoma, Basal Cell 2 Neoplasms 1 Melanoma 1 Exanthema 1 Carcinoma, Squamous Cell 1

Interventions

Cisplatin 76 Radiotherapy 43 Cetuximab 39 pembrolizumab 38 Paclitaxel 34 Carboplatin 33 Docetaxel 30 Fluorouracil 25 Radiotherapy, Intensity-Modulated 23 Nivolumab 18 Drug Therapy 14 Radiation 12 Erlotinib Hydrochloride 9 cemiplimab 8 Magnetic Resonance Spectroscopy 8 Blood Specimen Collection 8 130-nm albumin-bound paclitaxel 8 durvalumab 7 atezolizumab 7 Cyclophosphamide 7 Afatinib 7 Surveys and Questionnaires 6 Surgical Procedures, Operative 6 Panitumumab 6 Leucovorin 6 Esophagectomy 6 Chemoradiotherapy 6 fludarabine 5 aldesleukin 5 Oxaliplatin 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00488384 2018-07-19

Acitretin Plasma Levels Under Hemodialysis

University of Zurich

Phase 4 Withdrawn

Carcinoma, Squamous Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡